Semax (Spray)

Semax is a synthetic heptapeptide analog derived from adrenocorticotropic hormone (ACTH 4–10), studied in controlled laboratory environments for its interaction with neurotrophic signaling pathways and central nervous system research models. In experimental settings, Semax has been investigated for its influence on brain-derived neurotrophic factor (BDNF) expression research, peptide-mediated neuromodulation frameworks, and cognitive signaling pathway studies. The nasal spray format is utilized in laboratory research models examining intranasal delivery mechanisms and blood-brain barrier transport dynamics.

Preclinical investigations have examined Semax for its role in modulating neuropeptide signaling cascades, catecholaminergic pathway research, and stress-related regulatory systems within controlled experimental environments. Ongoing scientific studies continue to evaluate its receptor interactions, intracellular signaling responses, and transcriptional modulation characteristics in neurobiological research frameworks.

This research-grade Semax nasal spray is manufactured under strict laboratory-controlled standards. Each batch undergoes analytical verification to confirm molecular identity, purity, and structural consistency. Semax (Spray) is intended strictly for laboratory research and analytical purposes only and is not for human consumption.